Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,774
Closed -$269K 217
2018
Q3
$269K Sell
5,774
-254
-4% -$11.6K 0.1% 171
2018
Q2
$263K Hold
6,028
0.09% 177
2018
Q1
$277K Buy
6,028
+1,568
+35% +$76.1K 0.1% 169
2017
Q4
$225K Sell
4,460
-5
-0.1% -$263 0.08% 187
2017
Q3
$232K Sell
4,465
-247
-5% -$12K 0.09% 176
2017
Q2
$231K Buy
4,712
+381
+9% +$17.7K 0.09% 177
2017
Q1
$204K Buy
+4,331
New +$206K 0.09% 181
2016
Q4
Sell
-3,697
Closed -$146K 216
2016
Q3
$146K Buy
+3,697
New +$139K 0.07% 186

Other funds holding MET

BKS Advisors's MET Position: Q4 2018 in Review

BKS Advisors sold out of MetLife (MET) in Q4 2018, closing a stake of 5,774 shares — an estimated $269K sold.

BKS Advisors first reported a position in MET in Q3 2016 and held it in 8 quarters. The position peaked at $277K in Q1 2018. 1,009 funds tracked by Wall St. Rank hold MET as of Q4 2018.

  • BKS Advisors reported no remaining MetLife position as of Q4 2018 after selling out during the quarter.
  • BKS Advisors sold 5,774 MetLife shares in Q4 2018, an estimated $269K.
  • BKS Advisors first reported a position in MetLife in Q3 2016 and held it in 8 quarters.
  • BKS Advisors's MetLife position peaked at $277K in Q1 2018.
  • 1,009 funds tracked by Wall St. Rank held MetLife as of Q4 2018.

Based on BKS Advisors's 13F filing for Q4 2018, filed 30 Jan 2019.